Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04089332 · ClinicalTrials.gov registry record · NA
Insulin Resistance in Adolescents
A NA study of Insulin Resistance, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT04089332: Completed NA study of Insulin Resistance, sponsored by University of Wisconsin, Madison.
NCT04089332 is a NA study of Insulin Resistance that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 23 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04089332, a NA study of Insulin Resistance, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The growing population of adolescents with insulin resistance (IR) is predicted to create a large public health burden in the next few decades. This study examines the function of brain blood vessels and cognitive function, to test if increasing severity of IR in adolescents is related to reduced cognitive function and reduced brain blood vessel function. Findings from this study may help create treatments to delay or prevent some of the negative effects of IR on cognitive and vascular health.
Primary Outcome
HOMA-IR was measured from each participant at baseline (up to 1 hour visit) and a battery of cognitive instruments (listed here) were measured at a different study visit (2-3 hours of time). A relationship between individual HOMA-IR and Cognitive Function was hypothesized and a measured via Linear Regression (R-squared).
Conditions Studied
Interventions
- OTHER Oral Glucose Tolerance Test (OGTT)
- DEVICE 3 Tesla MRI
- DEVICE Intravenous Catheter
- OTHER Cognitive Tests
Study Locations (1)
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-10-04 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT04089332 record still lists
NCT04089332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 4 interventions - of which Oral Glucose Tolerance Test (OGTT) is the first listed.
NCT04089332 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04089332 about?
NCT04089332 is a clinical study titled "Insulin Resistance in Adolescents". The growing population of adolescents with insulin resistance (IR) is predicted to create a large public health burden in the next few decades. This study examines the function of brain blood vessels and cognitive function, to test if increasing severity of IR in adolescents is related to reduced co...
What is the current status of trial NCT04089332?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2019-10-04. Estimated completion is 2022-07-31.
What conditions does trial NCT04089332 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT04089332?
The interventions under investigation include: Oral Glucose Tolerance Test (OGTT) (OTHER), 3 Tesla MRI (DEVICE), Intravenous Catheter (DEVICE), Cognitive Tests (OTHER).
Who is sponsoring clinical trial NCT04089332?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04089332 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04089332's enrollment target sits among peer trials
23 101st of 120 higher than 20 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI